1.
Novel r(2)(p25q31) Cytogenetic Abnormality in a Pediatric Patient With Acute Leukemia of Ambiguous Lineage
by Bu, Lihong
American journal of clinical pathology, 2013, Vol.140 (suppl_1), p.A143-A143
2.
MDM2 analysis in the management of benign lipomas versus atypical lipomatous tumors/well-differentiated liposarcomas: A useful prognostication tool?
by Choi, Kyoo-Yoon
The American journal of surgery, 2022, Vol.224 (2), p.747
3.
A Rare Case of Pericardial NUT Midline Carcinoma Without Squamous Differentiation
by Chaffin, Joanna
American journal of clinical pathology, 2015, Vol.144 (suppl_2), p.A251-A251
4.
Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition
by Simons, A
Cytogenetic and genome research, 2013, Vol.141 (1), p.1-6
5.
Molecular Cytogenetic Analysis and Resequencing of Contactin Associated Protein-Like 2 in Autism Spectrum Disorders
by Bakkaloglu, Betul
American journal of human genetics, 2008, Vol.82 (1), p.165-173
6.
Myelodysplastic syndromes
by Adès, Lionel, MD
The Lancet (British edition), 2014, Vol.383 (9936), p.2239-2252
7.
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
by Lonial, Sagar
The lancet oncology, 2020, Vol.21 (2), p.207-221
8.
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
by Burnside, Rachel D
Cytogenetic and genome research, 2015, Vol.146 (2), p.89-99
9.
Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies
by Miller, David T
American journal of human genetics, 2010, Vol.86 (5), p.749-764
10.
Flow Cytometric Analysis of CD71 Expression as a Simple and Sensitive Tool for Detecting Dyserythropoiesis
by Liao, Xiaoyan
American journal of clinical pathology, 2015, Vol.144 (suppl_2), p.A159-A159
11.
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
by DeJesus-Hernandez, Mariely
Neuron (Cambridge, Mass.), 2011, Vol.72 (2), p.245-256
12.
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
by Renton, Alan E
Neuron (Cambridge, Mass.), 2011, Vol.72 (2), p.257-268
13.
Equine clinical cytogenetics: the past and future
by Lear, T.L
Cytogenetic and genome research, 2008, Vol.120 (1-2), p.42-49
14.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phas...
by Moreno, Carol
The lancet oncology, 2019, Vol.20 (1), p.43-56
15.
Clonal Cytogenetic Abnormalities in Morphologically Reactive Lymphoid Hyperplasia Associated With Solid Tumors
by Fedoriw, Yuri
American journal of clinical pathology, 2012, Vol.138 (suppl_2), p.A359-A359
16.
Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders
by Faundes, Víctor
American journal of human genetics, 2018, Vol.102 (1), p.175-187
17.
Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities
by Manning, Melanie
Genetics in medicine, 2010, Vol.12 (11), p.742-745
18.
Chronic myeloid leukaemia
by Apperley, Jane F, Prof
The Lancet (British edition), 2015, Vol.385 (9976), p.1447-1459
19.
Development and validation of a CGH microarray for clinical cytogenetic diagnosis
by Cheung, Sau W.
Genetics in medicine, 2005, Vol.7 (6), p.422-432
20.
A Search for Reliable Molecular Cytogenetic Markers of Prostate Cancer Prognosis That Can Distinguish the Minority of Patients Who Need Radical Treatment From the MajorityWho Do No...
by Tradonsky, Ali
American journal of clinical pathology, 2012, Vol.138 (suppl_1), p.A121-A121
